CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment / Sindre Rolstad en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.8 (Agosto)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.8 (Agosto) . - pp. 1091-1098 Título : CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment Tipo de documento: texto impreso Autores: Sindre Rolstad, Autor ; Joel Jakobsson, Autor ; Carl M. Sellgren, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1091-1098 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Fluido cerebroespinal, Trastorno bipolar, Neuropsicologia, Inflamación Resumen: Persistent cognitive impairment in the euthymic state of bipolar disorder is increasingly recognized. Mounting evidence also suggests an association between neuroinflammation and cognitive dysfunction. The purpose of this study was to test if cerebrospinal fluid (CSF) markers of neuroinflammation could account for cognitive impairment in bipolar disorder. Link: ./index.php?lvl=notice_display&id=26750 [artículo] CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment [texto impreso] / Sindre Rolstad, Autor ; Joel Jakobsson, Autor ; Carl M. Sellgren, Autor . - 2021 . - pp. 1091-1098. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.8 (Agosto) . - pp. 1091-1098 Palabras clave: Fluido cerebroespinal, Trastorno bipolar, Neuropsicologia, Inflamación Resumen: Persistent cognitive impairment in the euthymic state of bipolar disorder is increasingly recognized. Mounting evidence also suggests an association between neuroinflammation and cognitive dysfunction. The purpose of this study was to test if cerebrospinal fluid (CSF) markers of neuroinflammation could account for cognitive impairment in bipolar disorder. Link: ./index.php?lvl=notice_display&id=26750

Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts / Johan V. Sandberg en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.12 (Diciembre)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.12 (Diciembre) . - pp. 1907-1915 Título : Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts Tipo de documento: texto impreso Autores: Johan V. Sandberg, Autor ; Joel Jakobsson, Autor ; Erik Pålsson, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1907-1915 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Intento de suicidio, Fluido cerebroespinal, Neuropéptido, Prevención del suicidio, Biomarcador Resumen: The attempted and accomplished suicide rates in patients with bipolar disorder are 40–50% and 15–20%, respectively. No biological markers that help predict suicide been identified. Human and experimental animal data indicate that dysregulation of the neuropeptide Y (NPY) system plays a role in depression, anxiety, and posttraumatic stress disorder (PTSD). Link: ./index.php?lvl=notice_display&id=26952 [artículo] Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts [texto impreso] / Johan V. Sandberg, Autor ; Joel Jakobsson, Autor ; Erik Pålsson, Autor . - 2021 . - pp. 1907-1915. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.12 (Diciembre) . - pp. 1907-1915 Palabras clave: Trastorno bipolar, Intento de suicidio, Fluido cerebroespinal, Neuropéptido, Prevención del suicidio, Biomarcador Resumen: The attempted and accomplished suicide rates in patients with bipolar disorder are 40–50% and 15–20%, respectively. No biological markers that help predict suicide been identified. Human and experimental animal data indicate that dysregulation of the neuropeptide Y (NPY) system plays a role in depression, anxiety, and posttraumatic stress disorder (PTSD). Link: ./index.php?lvl=notice_display&id=26952

Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls / Erik Pålsson en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.1 (Enero)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 133-140 Título : Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls Tipo de documento: texto impreso Autores: Erik Pålsson, Autor ; Joel Jakobsson, Autor ; Kristoffer Södersten, Autor Fecha de publicación: 2021 Artículo en la página: pp. 133-140 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Ácido glutamico, Suero, Fluido cerebroespinal, N-metil-d-aspartato Resumen: Glutamate is the major excitatory neurotransmitter in the brain. Aberrations in glutamate signaling have been linked to the pathophysiology of mood disorders. Increased plasma levels of glutamate as well as higher glutamine+glutamate levels in the brain have been demonstrated in patients with bipolar disorder as compared to healthy controls. Link: ./index.php?lvl=notice_display&id=26853 [artículo] Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls [texto impreso] / Erik Pålsson, Autor ; Joel Jakobsson, Autor ; Kristoffer Södersten, Autor . - 2021 . - pp. 133-140. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 133-140 Palabras clave: Trastorno bipolar, Ácido glutamico, Suero, Fluido cerebroespinal, N-metil-d-aspartato Resumen: Glutamate is the major excitatory neurotransmitter in the brain. Aberrations in glutamate signaling have been linked to the pathophysiology of mood disorders. Increased plasma levels of glutamate as well as higher glutamine+glutamate levels in the brain have been demonstrated in patients with bipolar disorder as compared to healthy controls. Link: ./index.php?lvl=notice_display&id=26853

---

1 (1 - 3 / 3)